Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Gerardo Mata-Torres"'
Autor:
Angelina Daniela Moreno-Vargas, Adolfo Andrade-Cetto, Fernanda Artemisa Espinoza-Hernández, Gerardo Mata-Torres
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Croton guatemalensis Lotsy (Euphorbiaceae) is an important traditional medicine that is used by the Cakchiquels of Guatemala to control hyperglycemia in patients with type 2 diabetes. Previous studies have shown that administration of this plant indu
Externí odkaz:
https://doaj.org/article/e20f1ce2d1c0419e970cebf1232eb01a
Autor:
Daniel Rosas-Ramírez, Roberto Arreguín-Espinosa, Sonia Escandón-Rivera, Adolfo Andrade-Cetto, Gerardo Mata-Torres, Ricardo Pérez-Solís
Publikováno v:
Plants, Vol 13, Iss 5, p 644 (2024)
In the pursuit of identifying the novel resin glycoside modulators glucose-6-phosphatase and α-glucosidase enzymes, associated with blood sugar regulation, methanol-soluble extracts from the flowers of Ipomoea murucoides (cazahuate, Nahuatl), renown
Externí odkaz:
https://doaj.org/article/78d4d25cc39a44b99fe7bb63bb538b18
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Liver plays a pivotal role in maintaining blood glucose levels through complex processes which involve the disposal, storage, and endogenous production of this carbohydrate. Insulin is the hormone responsible for regulating hepatic glucose production
Externí odkaz:
https://doaj.org/article/caae6d14fe8d4f5b8c6680597b08f4b6
Autor:
Gerardo Mata-Torres, Adolfo Andrade-Cetto, Fernanda Artemisa Espinoza-Hernández, René Cárdenas-Vázquez
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
De novo hepatic glucose production or hepatic gluconeogenesis is the main contributor to hyperglycemia in the fasting state in patients with type 2 diabetes (T2D) owing to insulin resistance, which leads to at least twice as much glucose synthesis co
Externí odkaz:
https://doaj.org/article/36ab9b84037e43d7b0ad2f79db1a0d47
Autor:
Adolfo Andrade-Cetto, Fernanda Espinoza-Hernández, Gerardo Mata-Torres, Sonia Escandón-Rivera
Publikováno v:
Plants, Vol 10, Iss 10, p 2060 (2021)
Type 2 diabetes is a worldwide prevalent disease that is due to a progressive loss of adequate β-cell insulin secretion, frequently against a background of insulin resistance. In Mexican traditional medicine, the therapeutic use of hypoglycemic plan
Externí odkaz:
https://doaj.org/article/c03b06cde993420faae640bcb79a8945
Autor:
Espinoza-Hernández, Fernanda Artemisa, Valle, Gerardo Mata-Torres, González-Díaz, Anahi Elizabeth, Hernández-Martínez, Flavio Jesús, Sánchez-Villaseñor, Gabriela, Andrade-Cetto, Adolfo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bdefd379623277dc93ecd00f6591799b
Autor:
Fernanda Espinoza-Hernández, Gerardo Mata-Torres, Sonia Escandón-Rivera, Adolfo Andrade-Cetto
Publikováno v:
Plants
Volume 10
Issue 10
Plants, Vol 10, Iss 2060, p 2060 (2021)
Volume 10
Issue 10
Plants, Vol 10, Iss 2060, p 2060 (2021)
Type 2 diabetes is a worldwide prevalent disease that is due to a progressive loss of adequate β-cell insulin secretion, frequently against a background of insulin resistance. In Mexican traditional medicine, the therapeutic use of hypoglycemic plan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec28fd6b835b31748722d07024eae943
https://pubmed.ncbi.nlm.nih.gov/34685869
https://pubmed.ncbi.nlm.nih.gov/34685869
Publikováno v:
Evidence-Based Complementary and Alternative Medicine, Vol 2021 (2021)
The onset of type 2 diabetes (T2D) is a consequence of the progressive loss of adequate β-cell insulin secretion, which frequently occurs under a background of insulin resistance. Currently, nearly 13 million Mexicans are living with diabetes. Moreo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::791abcf097703c90903e0dbe8b441a64
Publikováno v:
Evidence-based Complementary and Alternative Medicine : eCAM
The onset of type 2 diabetes (T2D) is a consequence of the progressive loss of adequate β-cell insulin secretion, which frequently occurs under a background of insulin resistance. Currently, nearly 13 million Mexicans are living with diabetes. Moreo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::db657f914db1b2cebbad252035e63b28
https://pubmed.ncbi.nlm.nih.gov/33505497
https://pubmed.ncbi.nlm.nih.gov/33505497
Autor:
René Cárdenas-Vázquez, Adolfo Andrade-Cetto, Gerardo Mata-Torres, Fernanda Espinoza-Hernández
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 11 (2020)
Frontiers in Pharmacology, Vol 11 (2020)
De novo hepatic glucose production or hepatic gluconeogenesis is the main contributor to hyperglycemia in the fasting state in patients with type 2 diabetes (T2D) owing to insulin resistance, which leads to at least twice as much glucose synthesis co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e15262425b6a202a41abfe898d341a69
https://doi.org/10.3389/fphar.2020.00215
https://doi.org/10.3389/fphar.2020.00215